Twitter academia:
1. I am happy to announce xx (whatever trivial)
2. I am thrilled/excited that xx (papers, grants, promotion)
3. I am honored that xx ("awards" in all senses)
Adding to that list now:
"How I publish xx papers in x years"
What next? How I become god?
Check out the latest study from the @Timpson_Lab! 👀
Drs. @brooke_pereira_, @ShonaCRitchie1, @thomasrcox & co. report that NID2 is associated with poor patient outcomes in #pancreatic cancer, and that it is predominantly expressed by stromal cells.
🔎 https://t.co/2IANFtBNsv
FDA approves third anti-amyloid antibody for Alzheimer disease https://t.co/6yRJ27EYDw
Eli Lilly’s donanemab (Kisunla) is now approved for early symptomatic Alzheimer disease.
New work involving patient samples describes how natural killer cells use HLA-E signaling to exhibit memory-like behavior and antigen specificity. @BIDMChealth@DukeMedSchool
📄: https://t.co/3cd6KudaTL
The "Single cell Transcriptomics" hands-on workshop started @DBT_ILS today. The 4-day long workshop will include hand-on practical sessions as well as interactive sessions with experts from the field.
More info on https://t.co/wJ0bdZBE7i
@DBTIndia
2nd day of hands-on workshop on single cell transcriptomics using #10xgenomics platform. It was really fun to do everything in real. From PBMC➡️ library preparation. Kudos to @DBT_ILS and teams for this wonderful workshop. Two more days to go. @PremasLifeSc@10xGenomics
Exciting review paper on S1P signaling by Dr. K B Harikumar (@humheyglobal) in autoimmune disorders & tumor immunology. Grateful to be a small part & had fun creating all the figures using @BioRender's artistic tools! 🎨🧫
A new review article published from my laboratory in Progress in Lipid Research (IF:13.6).
https://t.co/xU3LPpL6mu
Thanks to @DBTIndia@IndiaDST@CSIR_IND for funding our research
Lactate in the tumor microenvironment is just bad news for tumor immune surveillance.
Out in @Cancer_Cell from @MDAndersonNews & collaborators:
MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma
https://t.co/RzdGGZ4RmH
Day 6 of great papers & perspectives in biology.
"Biology is more theoretical than physics," by J. Gunawardena (2013).
A brief history of theory --> discoveries in biology, including ion channels & the gene. My favorite bits are highlighted in green.
https://t.co/XmyZ6VDu64
New Jersey’s thirstiest pop musician @charlieputh talks to @Hiltyhilthilt about getting naked 🥵 being hungies, and new music.
⛓️: https://t.co/b3URD8767e
This is how a team of researchers taught a goldfish to pilot a tiny land vehicle. In their paper, the group describes the vehicle, how the fish were taught to use it and the navigational skills they displayed
[read more: https://t.co/9mQN8vGRXF]
1/2 #RGCB will be conducting a training program on flow cytometry, "Plunge into the flow get your basics right on flow cytometry & its application in modern biotechnology". It will be a 4-day program that includes sessions on ...
@DBTIndia
🔎 Looking for a good read?
Scientists explains the intricate process of how obesity and #DiabetesMellitus promote #pancreatic carcinogenesis and impair anticancer immunity in this review.
Learn more here:
📚 https://t.co/kdWJSRCGzG
HAPLN1 potentiates peritoneal metastasis in #PancreaticCancer
https://t.co/fu9WeERdcg
Intriguing molecule that has such divergent effects on metastases & immunomodulation based on source of expression (tumor cells, fibroblasts, lymphatic endothelium).
Huge #OpenAccess resource paper in @CD_AACR from @GustaveRoussy:
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer 👉🏽
META-PRISM cohort of 1,031 refractory metastatic tumors with comprehensive molecular profiling.
https://t.co/mEhpS96GcH
Excited to share our new work on direct protein-based genome editing in primary cells. We termed it Peptide-Assisted Genome Editing (PAGE) CRISPR-Cas platform. This platform allows rapid and effective editing of primary cells with minimal toxicity. https://t.co/tRdFwotwcW